ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Dow’s Ester Baiget to lead Novozymes

by Melody M. Bomgardner
November 2, 2019 | APPEARED IN VOLUME 97, ISSUE 43

09743-buscon8-baiget.jpg
Credit: Novozymes
Ester Baiget

Ester Baiget will become CEO of the Danish enzyme company Novozymes on Feb. 1. She will join the firm from Dow, where she is president of the industrial solutions business. In that role, Baiget expanded Dow’s market share and delivered double-digit growth and strong earnings, Novozymes says. It announced last month that CEO Peter Holk Nielsen would step down as part of an effort to reignite growth at the firm, which has struggled with demand and earnings shortfalls in recent quarters.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment